Second Quarter 2025 Results Key Financial Results Revenue: US$264.6m (up ...

Acadia Pharmaceuticals Inc. ACAD) on Wednesday reported second-quarter net income of $26.7 million. The San Diego-based ...

Detailed price information for Amn Healthcare Services Inc (AMN-N) from The Globe and Mail including charting and trades.

Acadia Pharma (ACAD) is scheduled to announce Q2 earnings results on Wednesday, August 6th, after market close.

Explore ACADIA Pharmaceuticals' Q2 2025 earnings highlights, featuring strong revenue growth, DAYBUE expansion, NUPLAZID guidance raise, and robust ...

Despite firming US sales of its Rett syndrome treatment Daybue, Neuren Pharmaceuticals (ASX:NEU) says two-thirds of eligible ...

Living within 3 miles of a golf course or using a vulnerable tap water source is associated with an increased risk for Parkinson Disease.

Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.

Shares little changed from Wednesday’s record; ASX hammered on monopoly chatter, costs hit; Domain to exit sharemarket after ...

Find the latest information on ACADIA Pharmaceuticals Inc. Common Stock (ACAD) insider activity and insider shares traded to make sound investments with Nasdaq.com.

The latest announcement is out from Saniona AB ( (SE:SANION) ).